Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: the Essence-TIMI 73b trial

Back

ESC Professional Premium Access

Olezarsen in patients with hypertriglyceridemia at high cardiovascular risk: the Essence-TIMI 73b trial

Session: HOT LINE 4

Topic: Drug therapy

Speaker: Doctor B. Bergmark (Boston, US)

Event: ESC Congress 2025

Congress Presentation

Add to my library

About the speaker

Doctor Brian Bergmark

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

2 presentations

0 follower

11 more presentations in this session

BaxHTN – Efficacy and safety of the aldosterone synthase inhibitor baxdrostat in patients with uncontrolled or resistant hypertension

Speaker: Professor B. Williams (London, GB)

Discussant review - BaxHTN

Speaker: Professor T. Guzik (Edinburgh, GB)

Access

Slides

Video

Panel discussion - BaxHTN

Access

KARDIA-3: Zilebesiran as Add-on Therapy in Adults with Hypertension and Established Cardiovascular Disease or at High Cardiovascular Risk

Speaker: Doctor N. Pagidipati (Durham, US)

Discussant review - KARDIA-3

Speaker: Professor M. Tomaszewski (Manchester, GB)

Access

Slides

Video

Access the full session

HOT LINE 4

Speakers: Doctor B. Bergmark, Professor B. Williams, Professor T. Guzik, Doctor N. Pagidipati, Professor M. Tomaszewski

Access

Video

About the event

ESC Congress 2025

29 August - 1 September 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources